Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

CD4+ T Cells Targeting Dominant and Cryptic Epitopes from Bacillus anthracis Lethal Factor.

Ascough S, Ingram RJ, Chu KK, Musson JA, Moore SJ, Gallagher T, Baillie L, Williamson ED, Robinson JH, Maillere B, Boyton RJ, Altmann DM.

Front Microbiol. 2016 Jan 5;6:1506. doi: 10.3389/fmicb.2015.01506. eCollection 2015.

2.

CD4+ T cell epitopes of FliC conserved between strains of Burkholderia: implications for vaccines against melioidosis and cepacia complex in cystic fibrosis.

Musson JA, Reynolds CJ, Rinchai D, Nithichanon A, Khaenam P, Favry E, Spink N, Chu KK, De Soyza A, Bancroft GJ, Lertmemongkolchai G, Maillere B, Boyton RJ, Altmann DM, Robinson JH.

J Immunol. 2014 Dec 15;193(12):6041-9. doi: 10.4049/jimmunol.1402273. Epub 2014 Nov 12.

3.

Anthrax lethal factor as an immune target in humans and transgenic mice and the impact of HLA polymorphism on CD4+ T cell immunity.

Ascough S, Ingram RJ, Chu KK, Reynolds CJ, Musson JA, Doganay M, Metan G, Ozkul Y, Baillie L, Sriskandan S, Moore SJ, Gallagher TB, Dyson H, Williamson ED, Robinson JH, Maillere B, Boyton RJ, Altmann DM.

PLoS Pathog. 2014 May 1;10(5):e1004085. doi: 10.1371/journal.ppat.1004085. eCollection 2014 May.

4.

Repertoire of HLA-DR1-restricted CD4 T-cell responses to capsular Caf1 antigen of Yersinia pestis in human leukocyte antigen transgenic mice.

Musson JA, Ingram R, Durand G, Ascough S, Waters EL, Hartley MG, Robson T, Maillere B, Williamson ED, Sriskandan S, Altmann D, Robinson JH.

Infect Immun. 2010 Oct;78(10):4356-62. doi: 10.1128/IAI.00195-10. Epub 2010 Jul 26.

5.

Immunogenicity of a Yersinia pestis vaccine antigen monomerized by circular permutation.

Chalton DA, Musson JA, Flick-Smith H, Walker N, McGregor A, Lamb HK, Williamson ED, Miller J, Robinson JH, Lakey JH.

Infect Immun. 2006 Dec;74(12):6624-31. Epub 2006 Sep 18.

6.

Mechanisms of major histocompatibility complex class II-restricted processing and presentation of the V antigen of Yersinia pestis.

Shim HK, Musson JA, Harper HM, McNeill HV, Walker N, Flick-Smith H, von Delwig A, Williamson ED, Robinson JH.

Immunology. 2006 Nov;119(3):385-92. Epub 2006 Aug 18.

7.

Sequential proteolytic processing of the capsular Caf1 antigen of Yersinia pestis for major histocompatibility complex class II-restricted presentation to T lymphocytes.

Musson JA, Morton M, Walker N, Harper HM, McNeill HV, Williamson ED, Robinson JH.

J Biol Chem. 2006 Sep 8;281(36):26129-35. Epub 2006 Jul 13.

8.

Distribution of productive antigen-processing activity for MHC class II presentation in macrophages.

von Delwig A, Musson JA, Shim HK, Lee JJ, Walker N, Harding CV, Williamson ED, Robinson JH.

Scand J Immunol. 2005 Sep;62(3):243-50.

10.

Attenuated Salmonella typhimurium htrA mutants cause fatal infections in mice deficient in NADPH oxidase and destroy NADPH oxidase-deficient macrophage monolayers.

Mutunga M, Graham S, De Hormaeche RD, Musson JA, Robinson JH, Mastroeni P, Khan CM, Hormaeche CE.

Vaccine. 2004 Sep 28;22(29-30):4124-31.

PMID:
15364466
11.

Regulation of peptide presentation by major histocompatibility complex class II molecules at the surface of macrophages.

von Delwig A, Musson JA, McKie N, Gray J, Robinson JH.

Eur J Immunol. 2003 Dec;33(12):3359-66.

12.

Differential processing of CD4 T-cell epitopes from the protective antigen of Bacillus anthracis.

Musson JA, Walker N, Flick-Smith H, Williamson ED, Robinson JH.

J Biol Chem. 2003 Dec 26;278(52):52425-31. Epub 2003 Oct 15.

13.

Processing of viable Salmonella typhimurium for presentation of a CD4 T cell epitope from the Salmonella invasion protein C (SipC).

Musson JA, Hayward RD, Delvig AA, Hormaeche CE, Koronakis V, Robinson JH.

Eur J Immunol. 2002 Sep;32(9):2664-71.

Supplemental Content

Loading ...
Support Center